Anfield Energy (AEC) | March 2012 | 617,547.06% |
Coda Octopus (CODA) | March 2012 | 1,580% |
Quest Resource (QRHC) | March 2012 | 266.67% |
Recon Technology (RCON) | March 2012 | 211.43% |
Netcapital (NCPL) | March 2012 | 133.33% |
Agenus (AGEN) | March 2012 | 118.38% |
Sellas Life Sciences (SLS) | March 2012 | 101.81% |
Supercom (SPCB) | March 2012 | 100% |
Patrick Industries (PATK) | March 2012 | 97.24% |
POET Technologies (POET) | March 2012 | 95.83% |
Intellicheck Mobilisa (IDN) | March 2012 | 91.36% |
Lifevantage (LFVN) | March 2012 | 87.07% |
XOMA Royalty (XOMA) | March 2012 | 82.24% |
BioRestorative Therapies (BRTX) | March 2012 | 75% |
Cellectar Biosciences (CLRB) | March 2012 | 70% |
Celsius (CELH) | March 2012 | 66.63% |
Harrow Health (HROW) | March 2012 | 60.71% |
Cps Technologies (CPSH) | March 2012 | 53.33% |
Soluna (SLNH) | March 2012 | 53.33% |
Sunshine Biopharma (SBFM) | March 2012 | 50% |
Sarepta Therapeutics (SRPT) | March 2012 | 49.51% |
Old Second Bancorp (OSBC) | March 2012 | 48.39% |
Reading International B (RDIB) | March 2012 | 47.25% |
Smith & Wesson Brands (SWBI) | March 2012 | 46.5% |
SurgePays (SURG) | March 2012 | 45.45% |
